Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Faraone

Showing results (161-170 of 343) with videos related to

Pageof 35
Sort By:
Psychiatry Research|June 1, 1991
A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depressionJ Biederman, J F Rosenbaum, E A Bolduc, et al.
The American Journal of Psychiatry|November 1, 1995
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidityJ Biederman, T Wilens, E Mick, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 24, 1997
Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorderJ Biederman, S V Faraone, W Weber, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1996
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?T J Spencer, J Biederman, M Harding, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 21, 2013
Daily life impairments associated with self-reported childhood/adolescent attention-deficit/hyperactivity disorder and experiences of diagnosis and treatment: results from the European Lifetime Impairment SurveyH Caci, M Doepfner, P Asherson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1990
Sex differences in the familial transmission of schizophreniaJ M Goldstein, S V Faraone, W J Chen, et al.
Clinical Pharmacology and Therapeutics|April 4, 2017
Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHDR Gomeni, Fmm Bressolle-Gomeni, T J Spencer, et al.
Psychiatry Research|August 15, 1998
Neuropsychological risk indicators for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probandsW S Kremen, S V Faraone, L J Seidman, et al.
Psychiatry Research|December 1, 1986
Neuroleptic bioavailability, psychosocial factors, and clinical status: a 1-year study of schizophrenic outpatients after dose reductionS V Faraone, J P Curran, T Laughren, et al.
Schizophrenia Research|June 1, 1994
Systematized delusions and neuropsychological function in paranoid and nonparanoid schizophreniaW S Kremen, L J Seidman, J M Goldstein, et al.
Pageof 35

Showing results (161-170 of 343) with videos related to

Sort By:
Pageof 35
Psychiatry Research|June 1, 1991
A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depressionJ Biederman, J F Rosenbaum, E A Bolduc, et al.
The American Journal of Psychiatry|November 1, 1995
Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidityJ Biederman, T Wilens, E Mick, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 24, 1997
Correspondence between DSM-III-R and DSM-IV attention-deficit/hyperactivity disorderJ Biederman, S V Faraone, W Weber, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 1, 1996
Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?T J Spencer, J Biederman, M Harding, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 21, 2013
Daily life impairments associated with self-reported childhood/adolescent attention-deficit/hyperactivity disorder and experiences of diagnosis and treatment: results from the European Lifetime Impairment SurveyH Caci, M Doepfner, P Asherson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1990
Sex differences in the familial transmission of schizophreniaJ M Goldstein, S V Faraone, W J Chen, et al.
Clinical Pharmacology and Therapeutics|April 4, 2017
Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHDR Gomeni, Fmm Bressolle-Gomeni, T J Spencer, et al.
Psychiatry Research|August 15, 1998
Neuropsychological risk indicators for schizophrenia: a preliminary study of female relatives of schizophrenic and bipolar probandsW S Kremen, S V Faraone, L J Seidman, et al.
Psychiatry Research|December 1, 1986
Neuroleptic bioavailability, psychosocial factors, and clinical status: a 1-year study of schizophrenic outpatients after dose reductionS V Faraone, J P Curran, T Laughren, et al.
Schizophrenia Research|June 1, 1994
Systematized delusions and neuropsychological function in paranoid and nonparanoid schizophreniaW S Kremen, L J Seidman, J M Goldstein, et al.
Pageof 35